Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Friday, October 30, 2026
earnings report
October 30, 2026
Q3 2026
Est. EPS: $24.25
Actual EPS: $20.07
EPS surprise: 21.56%
Company overview
Market Cap$95.5B
PriceUSD 927.89
P/E20.48
EPS (TTM)45.30
52-week high935.35
52-week low591.52
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410